Clinical Course for Patients With Trisomy 13 and 18 Pursuing Life-Prolonging Therapies Versus Comfort-Directed Care

Michelle C Perry Milligan1,2, Laura E Jackson3,4, Scott H Maurer1,5

  • 1Department of Pediatrics, University of Pittsburgh School of Medicine, 6619UPMC Children's Hospital of Pittsburgh, PA, USA.

Insights

Parental goals of care for infants with Trisomy 13 and 18 did not impact lifespan but significantly influenced treatment intensity, including hospital and ICU days. This finding can guide clinical decision-making for these complex genetic conditions.

Area of Science:

  • Genetics and Developmental Biology
  • Pediatric Medicine
  • Palliative Care

Background:

  • Care for infants with Trisomy 13 and 18 is advancing with increased medical and surgical options.
  • Understanding the link between parental goals of care and clinical outcomes is crucial for informed decision-making.

Purpose of the Study:

  • To describe and compare parental goals of care (GOC) with the clinical course of infants diagnosed with Trisomy 13 and 18.
  • To analyze the impact of GOC on treatment intensity and survival in these infants.

Main Methods:

  • Retrospective analysis of 28 infants diagnosed with Trisomy 13 or 18 between 2013-2019 at a single center.
  • Electronic health records were reviewed for diagnoses, hospitalization duration, interventions, GOC, and survival data.

Main Results:

  • Among 26 infants with complete Trisomy 13 or 18, 8 had life-prolonging goals and 18 had comfort care goals.
  • Life-prolonging GOC was associated with increased hospital days (70 vs. 12), ICU days (66 vs. 9), intubation rates, and in-ICU deaths.
  • No significant difference in length of life was observed between groups (p = 0.36).

Conclusions:

  • Parental GOC significantly influences treatment intensity but not the length of life for infants with complete Trisomy 13 or 18.
  • These findings can aid clinicians and families in navigating complex care decisions for these conditions.
Abstract

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.7K
Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
1.6K
Restorative Care01:19

Restorative Care

Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
2.2K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
173
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
316